Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China flag China · Delayed Price · Currency is CNY
7.84
+0.13 (1.69%)
Feb 3, 2026, 3:04 PM CST

SHE:002550 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
439.28439.95576.23409.26617.81516.11
Short-Term Investments
-192.964.95---
Trading Asset Securities
610.44273.8371.9867.4868.23234.28
Cash & Short-Term Investments
1,050906.67713.16476.73686.03750.39
Cash Growth
48.16%27.13%49.59%-30.51%-8.58%-13.35%
Accounts Receivable
280.4274.25275.52632.87447.67461.88
Other Receivables
22.1223.2416.92.482.564.81
Receivables
302.52297.48292.42635.35450.23466.69
Inventory
382.97426.81602.01536.48400.63315.97
Prepaid Expenses
----0.010.01
Other Current Assets
202.2362.7318.3938.7233.0423.96
Total Current Assets
1,9371,6941,6261,6871,5701,557
Property, Plant & Equipment
547.36563.6561.27616.39611.77599.56
Long-Term Investments
96.84160.08203.22156.7840.566.71
Goodwill
11.1411.1411.1411.1411.1411.14
Other Intangible Assets
108109.32113.14100.86106.92114.42
Long-Term Deferred Tax Assets
57.9975.2690.53101.4999.42105.52
Long-Term Deferred Charges
162.19138.0493.7760.3346.8538.14
Other Long-Term Assets
94.5215.33.0571.6721.8119.27
Total Assets
3,0152,8302,7662,8062,5082,452
Accounts Payable
59.2988.6441.1845.9771.23106.25
Accrued Expenses
27.2388.0689.7101.9499.5596.63
Short-Term Debt
-21.4956.31103.0593.5641.85
Current Income Taxes Payable
12.511.530.640.05-15.02
Current Unearned Revenue
5.339.689.7115.5819.6711.86
Other Current Liabilities
59.34148.2811.6312.3419.38
Total Current Liabilities
163.71223.39205.81278.22296.35290.98
Long-Term Unearned Revenue
88.4486.4681.8589.3593.4294.87
Long-Term Deferred Tax Liabilities
3.714.024.524.960.470.5
Total Liabilities
255.86313.87292.17372.53390.24386.35
Common Stock
1,2801,2801,2801,2801,2801,280
Additional Paid-In Capital
41.4241.6541.6536.2929.3825.58
Retained Earnings
1,6031,3691,1631,134960.89929.79
Treasury Stock
-170.86-170.86-30.09--145.05-154.38
Comprehensive Income & Other
-2.02-2.420.36-0.062.23-0.88
Total Common Equity
2,7512,5172,4552,4502,1272,080
Minority Interest
8.77-0.8718.98-16.95-9.09-14.56
Shareholders' Equity
2,7602,5172,4742,4332,1182,065
Total Liabilities & Equity
3,0152,8302,7662,8062,5082,452
Total Debt
-21.4956.31103.0593.5641.85
Net Cash (Debt)
1,050885.19656.85373.69592.48708.54
Net Cash Growth
52.46%34.76%75.78%-36.93%-16.38%35.81%
Net Cash Per Share
0.830.700.510.290.490.59
Filing Date Shares Outstanding
1,2501,2501,2751,2801,2801,280
Total Common Shares Outstanding
1,2501,2501,2751,2801,2801,280
Working Capital
1,7741,4701,4201,4091,2741,266
Book Value Per Share
2.202.011.931.911.661.63
Tangible Book Value
2,6322,3972,3312,3382,0091,954
Tangible Book Value Per Share
2.111.921.831.831.571.53
Buildings
-498.75498.75525.73524.28448.65
Machinery
-568.44558.3504.84461.29426.63
Construction In Progress
-61.258.1954.139.2476.54
Source: S&P Global Market Intelligence. Standard template. Financial Sources.